Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 3/2019

01-05-2019 | Keratoplasty | Clinical Investigation

Effect of topical steroid instillation on central corneal thickness in eyes with bullous keratopathy

Authors: Takashi Ono, Takuya Iwasaki, Chie Yukawa, Yosai Mori, Ryohei Nejima, Tadatoshi Tokunaga, Shiro Amano, Kazunori Miyata

Published in: Japanese Journal of Ophthalmology | Issue 3/2019

Login to get access

Abstract

Purpose

To examine the effects of topical steroid instillation on central corneal thickness in eyes with bullous keratopathy (BK).

Study design

Retrospective case series

Methods

Consecutive patients with BK who did not wish to receive corneal transplantation and were treated with 0.1% betamethasone eyedrops were included. Patients with BK treated with 5% sodium chloride (hypertonic saline) eyedrops served as controls. Central corneal thickness (CCT), best-corrected visual acuity (BCVA), intraocular pressure (IOP), BK etiology, and clinical courses from medical records were retrospectively reviewed. We compared the two groups for differences in CCT, BCVA and IOP before treatment and 2 weeks, 1 month, and 3 months after treatment.

Results

Eighteen eyes of 18 patients who were treated with betamethasone and 18 eyes of 18 patients who were treated with hypertonic saline were included. There was no significant difference in CCT between the two groups before treatment. The reduction of CCT in the betamethasone group was significantly larger than in the hypertonic saline group at 2 weeks (p = 0.002), 1 month (p = 0.02), and 3 months (p = 0.001) after treatment. Complications such as infectious keratitis and IOP rise did not occur during the observation period.

Conclusions

Topical steroid instillation reduced central corneal thickness in eyes with BK.
Literature
1.
go back to reference Inoue K, Amano S, Oshika T, Sawa M, Tsuru T. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:139–45.CrossRefPubMed Inoue K, Amano S, Oshika T, Sawa M, Tsuru T. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:139–45.CrossRefPubMed
2.
go back to reference Patel SV, Hodge DO, Bourne WM. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. Am J Ophthalmol. 2005;139:311–9.CrossRefPubMed Patel SV, Hodge DO, Bourne WM. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. Am J Ophthalmol. 2005;139:311–9.CrossRefPubMed
3.
go back to reference Ang M, Soh Y, Htoon HM, Mehta JS, Tan D. Five-year graft survival comparing descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2016;123:1646–52.CrossRefPubMed Ang M, Soh Y, Htoon HM, Mehta JS, Tan D. Five-year graft survival comparing descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2016;123:1646–52.CrossRefPubMed
4.
go back to reference Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25:987–90.CrossRefPubMed Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25:987–90.CrossRefPubMed
5.
go back to reference Stuart AJ, Romano V, Virgili G, Shortt AJ. Descemet’s membrane endothelial keratoplasty (DMEK) versus Descemet’s stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure. Cochrane Database Syst Rev. 2018;6:CD012097.PubMed Stuart AJ, Romano V, Virgili G, Shortt AJ. Descemet’s membrane endothelial keratoplasty (DMEK) versus Descemet’s stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure. Cochrane Database Syst Rev. 2018;6:CD012097.PubMed
6.
go back to reference Arora R, Jain S, Monga S, Narayanan R, Raina UK, Mehta DK. Efficacy of continuous wear PureVision contact lenses for therapeutic use. Contact Lens Anterior Eye. 2004;27:39–43.CrossRefPubMed Arora R, Jain S, Monga S, Narayanan R, Raina UK, Mehta DK. Efficacy of continuous wear PureVision contact lenses for therapeutic use. Contact Lens Anterior Eye. 2004;27:39–43.CrossRefPubMed
7.
go back to reference Knezovic I, Dekaris I, Gabric N, Cerovski J, Barisic A, Bosnar D, et al. Therapeutic efficacy of 5% NaCl hypertonic solution in patients with bullous keratopathy. Coll Antropol. 2006;30:405–8.PubMed Knezovic I, Dekaris I, Gabric N, Cerovski J, Barisic A, Bosnar D, et al. Therapeutic efficacy of 5% NaCl hypertonic solution in patients with bullous keratopathy. Coll Antropol. 2006;30:405–8.PubMed
8.
9.
go back to reference Hatou S, Yamada M, Mochizuki H, Shiraishi A, Joko T, Nishida T. The effects of dexamethasone on the Na, K-ATPase activity and pump function of corneal endothelial cells. Curr Eye Res. 2009;34:347–54.CrossRefPubMed Hatou S, Yamada M, Mochizuki H, Shiraishi A, Joko T, Nishida T. The effects of dexamethasone on the Na, K-ATPase activity and pump function of corneal endothelial cells. Curr Eye Res. 2009;34:347–54.CrossRefPubMed
10.
go back to reference Chikamoto N, Takahashi N, Wakuta M, Fujitsu Y, Nishida T. Recovery of corneal thickness promoted by glucocorticoid administration after phacoemulsification in eyes affected by Fuchs’ dystrophy. Jpn J Ophthalmol. 2008;52:336–9.CrossRefPubMed Chikamoto N, Takahashi N, Wakuta M, Fujitsu Y, Nishida T. Recovery of corneal thickness promoted by glucocorticoid administration after phacoemulsification in eyes affected by Fuchs’ dystrophy. Jpn J Ophthalmol. 2008;52:336–9.CrossRefPubMed
11.
go back to reference Luxenberg MN, Green K. Reduction of corneal edema with topical hypertonic agents. Am J Ophthalmol. 1971;71:847–53.CrossRefPubMed Luxenberg MN, Green K. Reduction of corneal edema with topical hypertonic agents. Am J Ophthalmol. 1971;71:847–53.CrossRefPubMed
12.
go back to reference Espana EM, Grueterich M, Sandoval H, Solomon A, Alfonso E, Karp CL, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29:279–84.CrossRefPubMed Espana EM, Grueterich M, Sandoval H, Solomon A, Alfonso E, Karp CL, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29:279–84.CrossRefPubMed
13.
go back to reference Ono T, Mori Y, Nejima R, Ogata M, Minami K, Miyata K. Sustainability of pain relief after corneal collagen cross-linking in eyes with bullous keratopathy. Asia Pac J Ophthalmol (Phila). 2018;7:291–5. Ono T, Mori Y, Nejima R, Ogata M, Minami K, Miyata K. Sustainability of pain relief after corneal collagen cross-linking in eyes with bullous keratopathy. Asia Pac J Ophthalmol (Phila). 2018;7:291–5.
14.
go back to reference Andrew NC, Woodward EG. The bandage lens in bullous keratopathy. Ophthalmic Physiol Opt. 1989;9:66–8.CrossRefPubMed Andrew NC, Woodward EG. The bandage lens in bullous keratopathy. Ophthalmic Physiol Opt. 1989;9:66–8.CrossRefPubMed
15.
go back to reference Koizumi N, Sakamoto Y, Okumura N, Okahara N, Tsuchiya H, Torii R, et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. InvestIG Ophthalmol Vis Sci. 2007;48:4519–26.CrossRef Koizumi N, Sakamoto Y, Okumura N, Okahara N, Tsuchiya H, Torii R, et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. InvestIG Ophthalmol Vis Sci. 2007;48:4519–26.CrossRef
16.
go back to reference Chen WL, Lin CT, Yao CC, Huang YH, Chou YB, Yin HS, et al. In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+–K+–ATPase activity of bovine corneal endothelial cells. Ocul Immunol Inflamm. 2006;14:215–23.CrossRefPubMed Chen WL, Lin CT, Yao CC, Huang YH, Chou YB, Yin HS, et al. In-vitro effects of dexamethasone on cellular proliferation, apoptosis, and Na+–K+–ATPase activity of bovine corneal endothelial cells. Ocul Immunol Inflamm. 2006;14:215–23.CrossRefPubMed
17.
go back to reference Yamaguchi T, Higa K, Suzuki T, Nakayama N, Yagi-Yaguchi Y, Dogru M, et al. Elevated cytokine levels in the aqueous humor of eyes with bullous keratopathy and low endothelial cell density. Investig Ophthalmol Vis Sci. 2016;57:5954–62.CrossRef Yamaguchi T, Higa K, Suzuki T, Nakayama N, Yagi-Yaguchi Y, Dogru M, et al. Elevated cytokine levels in the aqueous humor of eyes with bullous keratopathy and low endothelial cell density. Investig Ophthalmol Vis Sci. 2016;57:5954–62.CrossRef
18.
go back to reference Yagi-Yaguchi Y, Yamaguchi T, Higa K, Suzuki T, Aketa N, Dogru M, et al. Association between corneal endothelial cell densities and elevated cytokine levels in the aqueous humor. Sci Rep. 2017;7:13603.CrossRefPubMedPubMedCentral Yagi-Yaguchi Y, Yamaguchi T, Higa K, Suzuki T, Aketa N, Dogru M, et al. Association between corneal endothelial cell densities and elevated cytokine levels in the aqueous humor. Sci Rep. 2017;7:13603.CrossRefPubMedPubMedCentral
19.
go back to reference Narayanan R, Gaster RN, Kenney MC. Pseudophakic corneal edema: a review of mechanisms and treatments. Cornea. 2006;25:993–1004.CrossRefPubMed Narayanan R, Gaster RN, Kenney MC. Pseudophakic corneal edema: a review of mechanisms and treatments. Cornea. 2006;25:993–1004.CrossRefPubMed
20.
21.
go back to reference Sun JP, Chen WL, Huang JY, Hou YC, Wang IJ, Hu FR. Microbial keratitis after penetrating keratoplasty. Am J Ophthalmol. 2017;178:150–6.CrossRefPubMed Sun JP, Chen WL, Huang JY, Hou YC, Wang IJ, Hu FR. Microbial keratitis after penetrating keratoplasty. Am J Ophthalmol. 2017;178:150–6.CrossRefPubMed
Metadata
Title
Effect of topical steroid instillation on central corneal thickness in eyes with bullous keratopathy
Authors
Takashi Ono
Takuya Iwasaki
Chie Yukawa
Yosai Mori
Ryohei Nejima
Tadatoshi Tokunaga
Shiro Amano
Kazunori Miyata
Publication date
01-05-2019
Publisher
Springer Japan
Keyword
Keratoplasty
Published in
Japanese Journal of Ophthalmology / Issue 3/2019
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-019-00658-7

Other articles of this Issue 3/2019

Japanese Journal of Ophthalmology 3/2019 Go to the issue